life after glp-1 The Exit Plan: The first step-by-step guide to GLP-1s--using personalized nutrition, mindset, and your DNA to stay free for life and metabolic balance so energy feels steadier and fullness feels more natural throughout the day. When you stop GLP-1 medications,

Chiu and your anesthesia team if you have: Nausea or vomiting Constipation or bloating Abdominal pain or reflux A recent dose increase A newly started GLP-1 medication Poor appetite or low protein intake Rapid weight loss Diabetes or blood sugar changes A history of gastroparesis or slow digestion These details help your team decide whether to move forward, need a modified plan, or wait until symptoms improve

Cancer Res (2001) 61(8):32903

Read Guide Ready to Get Started

Sikiric, P., Drmic, D., Brcic, L., & Seiwerth, S

The expression of parathyroid hormone-related protein (PTHrP), which controls chondrocyte maturation during endochondral ossification, was enhanced in both articular cartilage and hypertrophic growth plate following selenium deficiency

And in 2025, Wegovy also received FDA accelerated approval for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, underscoring that these medications can impact disease processes well beyond body weight alone